Summary
The purpose of the present investigation was to study the effects of simultaneous manipulations of central cholinergic, adrenergic and glutamatergic systems on locomotion in an animal model of Parkinson's disease.
Mice were deprived of their monoamine stores by pretreatment with the monoamine depleter reserpine and the catecholamine synthesis inhibitor α-methyl-p-tyrosine, given 18 h and 60 min, respectively, before the acute experiment. Traditionally, only dopaminergic agonists have been shown to reverse the akinesia thus produced. However, in the present study it is demonstrated that if a muscarine receptor antagonist (atropine or biperiden) is combined with an α-adrenergic agonist/α-adrenergic agonist precursor (clonidine or l-α-methyl-dopa), a marked locomotor stimulation can be achieved, although either agent given alone is ineffective. Adding an NMDA antagonist (MK-801, ketamine or SDZ EAA494) to the combination biperiden+clonidine resulted in further potentiation of the locomotor stimulatory effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anden N-E (1979) Selective stimulation of central α-autoreceptors following treatment with α-methyldopa and FLA 136. Naunyn-Schmiedeberg's Arch Pharmacol 306:263–266
Andén N-E, Strömbom U (1975) Stimulation of central adrenergic alpha-receptors by l-dopa, α-methyldopa and clonidine. In: Davies DS, Reid JL (eds) Central action of drugs in blood pressure regulation. Pitman Medical, Tunbridge Wells, pp 225–236
Bylund DB (1988) Subtypes of α2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci 9:356–361
Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164–173
Carlsson M, Carlsson A (1989a) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221–226
Carlsson M, Carlsson A (1989b) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77:65–71
Carlsson M, Carlsson A (1989c) Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine. J Neural Transm 1:317–322 (P-D Sect)
Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272–276
Carlsson M, Svensson A (1990a) Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacol Biochem Behav 36:45–50
Carlsson M, Svensson A (1990b) The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci 47:1729–1736
Perry BD, Simon PR, U'Prichard DC (1983) Interactions of neuroleptic compounds at α2-adrenergic receptor affinity states in bovine caudate nucleus. Eur J Pharmacol 95:315–318
Ramirez OA, Wang RY (1986) Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Res 362:165–170
Author information
Authors and Affiliations
Additional information
Send offprint requests to M. Carlsson at the above address
Rights and permissions
About this article
Cite this article
Carlsson, M., Svensson, A. & Carlsson, A. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice. Naunyn-Schmiedeberg's Arch Pharmacol 343, 568–573 (1991). https://doi.org/10.1007/BF00184286
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184286